NCCN Maintains Qualification as CMS-Approved Provider-Led Entity for the Development of Imaging Appropriate Use Criteria

National Comprehensive Cancer Network

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® has again qualified as a provider-led entity (PLE) for the Medicare Appropriate Use Criteria (AUC) Program by Centers for Medicare & Medicaid Services (CMS), the nation’s largest health payer. NCCN earned its initial qualification in 2016 when CMS launched the new program to increase the rate of appropriate advanced diagnostic imaging services provided to Medicare beneficiaries.

NCCN was recognized as one of the first groups qualified to develop AUC that can facilitate decision-making for diagnostic imaging in patients with cancer. PLEs are qualified for a period of five years, and, after close review of the 2021 renewal application, CMS determined that NCCN continues to meet the requirements to be a PLE. NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) are accessible for free to registered users of NCCN.org through an easy-to-use database at NCCN.org/ImagingAUC.

READ:  STRATA Skin Sciences Expands into Israel with Leading Medical Device Distributor

“NCCN is honored to remain among the distinguished group of CMS-approved provider-led entities for development of diagnostic imaging AUC,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “This recognition advances NCCN’s commitment to high-quality care while assuring the appropriate use of advanced diagnostic imaging for people with cancer. During the last five years, we have greatly expanded the library of evidence-based recommendations in the NCCN Imaging AUC™ and we will continue to update and enhance this resource based on scientific and medical advances.”

NCCN Imaging AUC™ are based directly on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance. Additional information includes the indication, imaging modality, and frequency of use, as well as clinical notes related to each specific recommendation. NCCN Imaging AUC™ also include information on disease stage and histology. All imaging procedures recommended in the NCCN Guidelines®, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT) and ultrasound, are included within NCCN Imaging AUC™.

READ:  Police Attempt to Identify Suspects in Theft at the GAP in Plymouth Township

NCCN Imaging AUC™ are available for more than 67 cancer types in addition to screening and supportive care. Additional NCCN Imaging AUC™ will be published in the coming months. To access the NCCN Imaging AUC™ and view a user guide, visit NCCN.org/ImagingAUC.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.